Diddy wrote, "I have said before that I have become less
Diddy wrote, "I have said before that I have become less optimistic. Primarily because of the failures if and around CD12, and our apparent inability to retain good people."
I'm not sure which good people you're referring to. Dr. Rahman seemed nice, but his rambling talk about not being able to put his son to bed immediately set off warning bells, as did his resume w its job-hopping. Then he didn't deliver on his HIV BLA promises. Dr. Patterson also seemed nice, but now it seems likely that he was and is bent on either selling off his meh company for hundreds of millions (!) or else snatching the patent on Leronlimab from under his employer's noses.
Re the failures of CD 12. They've made me less optimistic too. Not about the drug, but about the FDA. I no longer believe they want the drug to save lives; I believe they want the drug to fail, so their friends and sponsors at big pharmas can line their pockets ever more fully. Let's say the Brazil trial is at least as successful as the 14-day version of CD12, with an 82% reduction in mortality over placebo/soc. What will the FDA response be, after their letter claiming that Leron has no clinical benefit? I'd like to say they will do their duty. I also hope it will be sunny this week. Both things might happen.
17
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...
Continue Reading
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....
Continue Reading
Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...
Continue Reading
Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...
Continue Reading
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue Reading
Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...
Continue Reading
Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...
Continue Reading
China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...
Continue Reading
Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...
Continue Reading
Top 5 Most Recently Viewed Articles
MEXC and Aptos Collaboration Recently, MEXC has announced an exciting collaboration with Aptos, creating a series of events centered around Aptos' native token, APT. This partnership offers a total prize pool of an astounding 1.5 million USDT, which is sure to catch the attention of many crypto enthusiasts and traders. Overview of the Events The events are designed to...
Continue Reading
Jim Cramer's Perspective on Shopify's Growth Potential Recently, renowned financial commentator Jim Cramer expressed optimism regarding Shopify Inc. (NASDAQ: SHOP), suggesting that the company is poised for significant growth. Cramer shared these insights on CNBC's "Mad Money", emphasizing that Shopify's innovative capabilities and expanding market share indicate a...
Continue Reading
Citrin Cooperman Expands Its Reach Citrin Cooperman has made significant strides in enhancing its service offerings with the recent announcement of its agreement to acquire the Clearview Group. This acquisition marks a pivotal moment for Citrin Cooperman as it seeks to strengthen its presence in the Mid-Atlantic region. Clearview Group is a well-respected management...
Continue Reading
The Importance of Amazon's Upcoming Earnings Report Shares of tech giant Amazon.com (NASDAQ: AMZN) are currently hovering just above $230 as the company prepares for its first earnings report of the year. This report holds substantial weight as it comes after a period where Amazon has struggled to break through its record highs from last November. The stock is showing...
Continue Reading
Aquablation Therapy Triumphs at EAU 2025: A New Era in BPH Treatment SAN JOSE, Calif. – PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is thrilled to share groundbreaking results from the WATER III trial, an independent study that puts Aquablation therapy at the forefront of treatment for benign prostatic hyperplasia (BPH). At the recent European Association of Urology...
Continue Reading